| 摘要 |
The use of a 4-pyranone-2-carboxylic acid which contains an iodine atom, an optionally substituted alkoxy group or at least two substituents on the benzene ring, or of a pharmaceutically utilisable derivative thereof, in the treatment or prophylaxis of cataracts, retinopathies, neuropathies, angiopathies or nephropathies or other secondary manifestations associated with diabetes or galactosaemia. |
